Exane Derivatives’s Hercules Capital HTGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$41.7K Hold
3,094
0.02% 325
2022
Q1
$55.9K Sell
3,094
-370
-11% -$6.5K 0.02% 558
2021
Q4
$57.5K Hold
3,464
0.01% 481
2021
Q3
$57.5K Sell
3,464
-1,336
-28% -$22.7K 0.01% 604
2021
Q2
$82.8K Sell
4,800
-281
-6% -$4.81K 0.02% 568
2021
Q1
$81.4K Buy
+5,081
New +$78.8K 0.02% 448

Other funds holding HTGC

Exane Derivatives's HTGC Position: Q2 2022 in Review

Exane Derivatives held its Hercules Capital (HTGC) position steady in Q2 2022 at 3,094 shares worth $41.7K. The position accounts for 0.02% of the portfolio, ranked #325.

Exane Derivatives first reported a position in HTGC in Q1 2021 and has held it in 6 quarters since. The position peaked at $82.8K in Q2 2021. 249 funds tracked by Wall St. Rank hold HTGC as of Q2 2022.

  • Exane Derivatives held 3,094 shares of Hercules Capital worth $41.7K as of Q2 2022.
  • Exane Derivatives left its Hercules Capital share count unchanged in Q2 2022.
  • Hercules Capital made up 0.02% of Exane Derivatives's portfolio in Q2 2022, its #325 holding.
  • Exane Derivatives first reported a position in Hercules Capital in Q1 2021 and has held it in 6 quarters since.
  • Exane Derivatives's Hercules Capital position peaked at $82.8K in Q2 2021.
  • 249 funds tracked by Wall St. Rank held Hercules Capital as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.